Elevated levels of miR-181c and miR-633 in the CSF of patients with MS: A validation study.

Svenja KramerArash HaghikiaClaudia BangKristian ScherfAngelika PfanneAlexander DuschaJohannes KaislerBarbara GiseviusRalf GoldThomas ThumAiden Haghikia

Published in: Neurology(R) neuroimmunology & neuroinflammation (2019)

This study provides Class III evidence that CSF-derived miR-181c and miR-633 distinguish patients with MS from patients with OND.

Keyphrases

cell proliferation
long non coding rna
long noncoding rna
multiple sclerosis
mass spectrometry
ms ms
cerebrospinal fluid